TRAIL receptor-binding agents have therapeutic effects on tumor inhibition in vitro and in vivo, alone or in combination with an anti-cancer biologic. In particular, methods for the treatment of cancer include administering a TRAIL receptor binding agent, alone or in combination with TRAIL and/or interferon α-2b.